Pavesio Alessandra 4
4 · Bioventus Inc. · Filed Feb 14, 2022
Insider Transaction Report
Form 4
Pavesio Alessandra
SVP & Chief Science Officer
Transactions
- Tax Payment
Class A Common Stock
2022-02-10$12.88/sh+73,915$952,025→ 118,793 total - Exercise/Conversion
Class A Common Stock
2022-02-10+191,708→ 192,708 total - Exercise/Conversion
Phantom Profit Units
2022-02-10−191,708→ 0 total→ Class A Common Stock (191,708 underlying)
Footnotes (1)
- [F1]Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.